Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.44 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | GUSB | P08236 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | C1R | P00736 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6367677 | 0.78 | MAPT (0.52) | MAPTKMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL6106516 | 0.76 | NPC1 (0.58) | MAPTKMT2ANPC1RAB9AMAPK1 | |
| SCHEMBL10553914 | 0.75 | MAPT (0.49) | MAPTKMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL11477671 | 0.74 | RAB9A (0.61) | MAPTKMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL27598305 | 0.73 | MAPT (0.43) | MAPTKMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL2213047 | 0.72 | ALDH1A1 (0.60) | MAPTKMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL14374411 | 0.72 | MAPT (0.50) | MAPTKMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL11672909 | 0.70 | ALDH1A1 (0.60) | MAPTKMT2AALDH1A1ADAMTS4TDP1 | |
| SCHEMBL2431833 | 0.69 | CYP1A2 (0.63) | MAPTALDH1A1ADAMTS4TDP1 | |
| SCHEMBL2431836 | 0.69 | CYP1A2 (0.63) | MAPTALDH1A1ADAMTS4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1389616-B1 | 3,4-Dihalobenzylpiperidine derivatives and their medical use | MITSUBISHI TANABE PHARMA CORP (JP) | 2011-07-27 | — | — | EP | disclosed |
| CN-100384838-C | Novel benzylpiperidine compound | MITSUBISHI PHARMA CORP (JP) | 2008-04-30 | — | — | CN | disclosed |
| US-7115635-B2 | Benzylpiperidine compound | MITSUBISHI PHARMA CORPORATION (JP) | 2006-10-03 | — | — | US | disclosed |
| US-20040158071-A1 | Chemokine inhibitors and stability in blood | MITSUBISHI PHARMA CORPORATION (JP) | 2004-08-12 | — | — | US | disclosed |
| CN-1505626-A | Novel benzylpiperidine compound | ������ҩ��ʽ���� | 2004-06-16 | — | — | CN | disclosed |
| EP-1389616-A1 | NOVEL BENZYLPIPERIDINE COMPOUND | Mitsubishi Pharma Corporation (JP) | 2004-02-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040158071-A1 | Chemokine inhibitors and stability in blood | CCL2, CXCR1, CCR5 | MAPT 4797/4885KMT2A 3818/4885ALDH1A1 521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.